Status:
WITHDRAWN
New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
University of Washington
Denver Health Medical Center
Conditions:
Renal Insufficiency, Acute
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.
Detailed Description
Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 \[IL-18\] and urine neutr...
Eligibility Criteria
Inclusion
- First time liver transplant recipient
- Cadaveric or living donor livers
Exclusion
- Unconscious patients or patients who cannot give consent
- Pregnant women
- Prisoners
- Patients receiving dialysis before or during liver transplant operation
- Patients receiving simultaneous liver-kidney transplants
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00855127
Start Date
January 1 2009
End Date
July 1 2013
Last Update
June 1 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Denver
Aurora, Colorado, United States, 80045
2
University of Washington
Seattle, Washington, United States, 98105